Frontiers in Immunology (Jan 2022)
Acetate Improves the Killing of Streptococcus pneumoniae by Alveolar Macrophages via NLRP3 Inflammasome and Glycolysis-HIF-1α Axis
- Marina Gomes Machado,
- Marina Gomes Machado,
- Marina Gomes Machado,
- Marina Gomes Machado,
- Marina Gomes Machado,
- Marina Gomes Machado,
- Thiago Andrade Patente,
- Yves Rouillé,
- Yves Rouillé,
- Yves Rouillé,
- Yves Rouillé,
- Yves Rouillé,
- Severine Heumel,
- Severine Heumel,
- Severine Heumel,
- Severine Heumel,
- Severine Heumel,
- Eliza Mathias Melo,
- Lucie Deruyter,
- Lucie Deruyter,
- Lucie Deruyter,
- Lucie Deruyter,
- Lucie Deruyter,
- Benoit Pourcet,
- Benoit Pourcet,
- Benoit Pourcet,
- Benoit Pourcet,
- Valentin Sencio,
- Valentin Sencio,
- Valentin Sencio,
- Valentin Sencio,
- Valentin Sencio,
- Mauro Martins Teixeira,
- François Trottein,
- François Trottein,
- François Trottein,
- François Trottein,
- François Trottein
Affiliations
- Marina Gomes Machado
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France
- Marina Gomes Machado
- Centre National de la Recherche Scientifique, UMR 9017, Lille, France
- Marina Gomes Machado
- Institut National de la Santé et de la Recherche Médicale U1019, Lille, France
- Marina Gomes Machado
- Centre Hospitalier Universitaire de Lille, Lille, France
- Marina Gomes Machado
- Institut Pasteur de Lille, Lille, France
- Marina Gomes Machado
- Department of Biochemistry and Immunology, Federal University of Minas Gerais, Belo Horizonte, Brazil
- Thiago Andrade Patente
- Department of Parasitology, Leiden University Medical Center, Leiden, Netherlands
- Yves Rouillé
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France
- Yves Rouillé
- Centre National de la Recherche Scientifique, UMR 9017, Lille, France
- Yves Rouillé
- Institut National de la Santé et de la Recherche Médicale U1019, Lille, France
- Yves Rouillé
- Centre Hospitalier Universitaire de Lille, Lille, France
- Yves Rouillé
- Institut Pasteur de Lille, Lille, France
- Severine Heumel
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France
- Severine Heumel
- Centre National de la Recherche Scientifique, UMR 9017, Lille, France
- Severine Heumel
- Institut National de la Santé et de la Recherche Médicale U1019, Lille, France
- Severine Heumel
- Centre Hospitalier Universitaire de Lille, Lille, France
- Severine Heumel
- Institut Pasteur de Lille, Lille, France
- Eliza Mathias Melo
- Department of Biochemistry and Immunology, Federal University of Minas Gerais, Belo Horizonte, Brazil
- Lucie Deruyter
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France
- Lucie Deruyter
- Centre National de la Recherche Scientifique, UMR 9017, Lille, France
- Lucie Deruyter
- Institut National de la Santé et de la Recherche Médicale U1019, Lille, France
- Lucie Deruyter
- Centre Hospitalier Universitaire de Lille, Lille, France
- Lucie Deruyter
- Institut Pasteur de Lille, Lille, France
- Benoit Pourcet
- Centre Hospitalier Universitaire de Lille, Lille, France
- Benoit Pourcet
- Institut Pasteur de Lille, Lille, France
- Benoit Pourcet
- Institut National de la Santé et de la Recherche Médicale U1011, Lille, France
- Benoit Pourcet
- Univ. Lille, U1011 – European Genomic Institute for Diabetes EGID, Lille, France
- Valentin Sencio
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France
- Valentin Sencio
- Centre National de la Recherche Scientifique, UMR 9017, Lille, France
- Valentin Sencio
- Institut National de la Santé et de la Recherche Médicale U1019, Lille, France
- Valentin Sencio
- Centre Hospitalier Universitaire de Lille, Lille, France
- Valentin Sencio
- Institut Pasteur de Lille, Lille, France
- Mauro Martins Teixeira
- Department of Biochemistry and Immunology, Federal University of Minas Gerais, Belo Horizonte, Brazil
- François Trottein
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France
- François Trottein
- Centre National de la Recherche Scientifique, UMR 9017, Lille, France
- François Trottein
- Institut National de la Santé et de la Recherche Médicale U1019, Lille, France
- François Trottein
- Centre Hospitalier Universitaire de Lille, Lille, France
- François Trottein
- Institut Pasteur de Lille, Lille, France
- DOI
- https://doi.org/10.3389/fimmu.2022.773261
- Journal volume & issue
-
Vol. 13
Abstract
Short-chain fatty acids (SCFAs) are metabolites produced mainly by the gut microbiota with a known role in immune regulation. Acetate, the major SCFA, is described to disseminate to distal organs such as lungs where it can arm sentinel cells, including alveolar macrophages, to fight against bacterial intruders. In the current study, we explored mechanisms through which acetate boosts macrophages to enhance their bactericidal activity. RNA sequencing analyses show that acetate triggers a transcriptomic program in macrophages evoking changes in metabolic process and immune effector outputs, including nitric oxide (NO) production. In addition, acetate enhances the killing activity of macrophages towards Streptococcus pneumoniae in an NO-dependent manner. Mechanistically, acetate improves IL-1β production by bacteria-conditioned macrophages and the latter acts in an autocrine manner to promote NO production. Strikingly, acetate-triggered IL-1β production was neither dependent of its cell surface receptor free-fatty acid receptor 2, nor of the enzymes responsible for its metabolism, namely acetyl-CoA synthetases 1 and 2. We found that IL-1β production by acetate relies on NLRP3 inflammasome and activation of HIF-1α, the latter being triggered by enhanced glycolysis. In conclusion, we unravel a new mechanism through which acetate reinforces the bactericidal activity of alveolar macrophages.
Keywords
- alveolar macrophages
- short chain fatty acid
- immunometabolism
- Streptococcus pneumoniae
- innate immunity
- nitric oxide